United Kingdom
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.24 B
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
2 |
USD 12.85 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
3 |
USD 8.10 M
|
June 30, 2024 | USD 23.61 | -1.99% |
|
United Kingdom |
|
4 |
USD 4.46 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
5 |
USD -2.16 M
|
Dec. 31, 2023 | USD 0.20 | -3.39% |
|
United Kingdom |
|
6 |
USD -2.29 M
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
7 |
USD -2.46 M
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
8 |
USD -2.89 M
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
9 |
USD -5.38 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
10 |
USD -6.41 M
|
Dec. 31, 2023 | USD 0.06 | 0.38% |
|
United Kingdom |
|
11 |
USD -6.50 M
|
March 31, 2024 | USD 1.69 | NA |
|
United Kingdom |
|
12 |
USD -9.10 M
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
13 |
USD -10.24 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
14 |
USD -10.52 M
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
15 |
USD -11.67 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
16 |
USD -13.09 M
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
17 |
USD -16.81 M
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
18 |
USD -22.82 M
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
19 |
USD -28.42 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
20 |
USD -44.62 M
|
June 30, 2024 | USD 0.07 | -16.83% |
|
United Kingdom |
|
21 |
USD -59.65 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
22 |
USD -63.11 M
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
23 |
USD -171.28 M
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
24 |
USD -189.95 M
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
25 |
USD -195.03 M
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
The Vaccines company in United Kingdom with the highest Operating Income is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD 4.24 B.
The Vaccines company in United Kingdom with the lowest Operating Income is Autolus Therapeutics plc (NasdaqGS: AUTL) at USD -195.03 M.
The top 10 Vaccines companies in United Kingdom by Operating Income are Roivant Sciences Ltd., hVIVO plc, Genus plc, ECO Animal Health Group plc, OptiBiotix Health Plc, Genflow Biosciences plc, Roquefort Therapeutics plc, Fusion Antibodies plc, Oncimmune Holdings plc and Poolbeg Pharma PLC.
The bottom 10 Vaccines companies in United Kingdom by Operating Income are Autolus Therapeutics plc, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc, Silence Therapeutics plc, Immunocore Holdings plc, Allergy Therapeutics plc, Mereo BioPharma Group plc, Scancell Holdings plc, Akari Therapeutics, Plc and Synairgen plc.